 | Recursion Pharmaceuticals, Inc. | |||
| NMS : RXRX || Location: United States | ||||
$7.35-0.05 (-0.68%) |
3.95 M | 7.14 - 7.44 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 39.762 M |
| March 15, 2024 | 43.520 M |
| Feb. 29, 2024 | 42.816 M |
| Feb. 15, 2024 | 38.241 M |
| Jan. 31, 2024 | 38.273 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.46 | -0.42 | 8.24% |
| 09/30/2023 | -0.39 | -0.43 | -9.50% |
| 06/30/2023 | -0.38 | -0.38 | 0.47% |
| 03/31/2023 | -0.36 | -0.34 | 4.23% |
| 12/31/2022 | -0.30 | -0.31 | -4.80% |
RXRX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 227.143M | Shares Float | 188.279M |
| Short Float | 39.762M | Market Cap | 1669.50M |
| Institution ownership | 92.47% | Insider ownership | 5.653% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.58 | Forward EPS | -1.86 |